| 127 |
Nocodazole
|
-
Nocodazole, CAS-RN: 31430-18-9, DTXSID9031800
|
106: Chemical binding to tubulin in oocytes leading to aneuploid offspring
|
| 128 |
Benomyl
|
-
Benomyl, CAS-RN: 17804-35-2, DTXSID5023900
|
2 AOPs
|
| 129 |
Carbendazim
|
-
Carbendazim, CAS-RN: 10605-21-7, DTXSID4024729
|
None
|
| 130 |
Thiabendazole
|
-
Thiabendazole, CAS-RN: 148-79-8, DTXSID0021337
|
None
|
| 131 |
Vincristine
|
-
Vincristine, CAS-RN: 57-22-7, DTXSID1032278
|
None
|
| 132 |
Hydrocarbons, various
|
|
None
|
| 133 |
Phenobarbital
|
-
Phenobarbital, CAS-RN: 50-06-6, DTXSID5021122
|
2 AOPs
|
| 134 |
Dichloroacetic Acid
|
-
Dichloroacetic acid, CAS-RN: 79-43-6, DTXSID2020428
|
None
|
| 135 |
Cyp2f2 substrates
|
|
None
|
| 136 |
Vinclozalin
|
|
None
|
| 137 |
Flutamide
|
-
Flutamide, CAS-RN: 13311-84-7, DTXSID7032004
|
4 AOPs
|
| 138 |
Bromocriptine
|
-
Bromocriptine, CAS-RN: 25614-03-3, DTXSID1022687
|
None
|
| 139 |
Propylene oxide
|
|
None
|
| 140 |
Nitisinone
|
|
None
|
| 141 |
Tembotrione
|
-
Tembotrione, CAS-RN: 335104-84-2, DTXSID5047037
|
None
|
| 142 |
Chloroform
|
-
Chloroform, CAS-RN: 67-66-3, DTXSID1020306
|
None
|
| 143 |
Androstenedione
|
|
None
|
| 144 |
Thiamethoxam
|
-
Thiamethoxam, CAS-RN: 153719-23-4, DTXSID2034962
|
None
|
| 145 |
Finasteride
|
|
3 AOPs
|
| 146 |
SACCHARIN, CALCIUM SALT
|
|
None
|
| 147 |
Dibenzo-p-dioxin
|
-
Dibenzo-p-dioxin, CAS-RN: 262-12-4, DTXSID8020410
|
131: Aryl hydrocarbon receptor activation leading to uroporphyria
|
| 148 |
Polychlorinated biphenyl
|
|
5 AOPs
|
| 149 |
Polychlorinated dibenzofurans
|
|
150: Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF
|
| 150 |
Hexachlorobenzene
|
-
Hexachlorobenzene, CAS-RN: 118-74-1, DTXSID2020682
|
131: Aryl hydrocarbon receptor activation leading to uroporphyria
|
| 151 |
GW6471
|
|
6: Antagonist binding to PPARα leading to body-weight loss
|